Additive toxicity of β-amyloid by a novel bioactive peptide in vitro: possible implications for Alzheimer's disease.
BACKGROUND: β-amyloid is regarded as a significant factor in Alzheimer's disease: but inefficient therapies based on this rationale suggests that additional signalling molecules or intermediary mechanisms must be involved in the actual initiation of the characteristic degeneration of neurons. O...
Main Authors: | Sara Garcia-Ratés, Matthew Lewis, Rosemary Worrall, Susan Greenfield |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3563650?pdf=render |
Similar Items
-
Amyloid peptide toxicity in an animal model of Alzheimer disease.
by: Liza Gross
Published: (2007-11-01) -
Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer’s Disease
by: Cosmin Stefan Mocanu, et al.
Published: (2020-10-01) -
β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer’s Disease
by: Xiaojuan eSun, et al.
Published: (2015-09-01) -
Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease.
by: Anna Itkin, et al.
Published: (2011-03-01) -
In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
by: Ann Tiiman, et al.
Published: (2015-09-01)